Literature DB >> 1597470

Secretion and biological activities of heparin-binding growth-associated molecule. Neurite outgrowth-promoting and mitogenic actions of the recombinant and tissue-derived protein.

E Raulo1, I Julkunen, J Merenmies, R Pihlaskari, H Rauvala.   

Abstract

The cDNA for the developmentally regulated, neurite outgrowth-promoting protein HB-GAM (heparin-binding growth-associated molecule) was recently cloned and shown to encode a novel lysine-rich sequence that is homologous with retinoic acid-induced sequences suggested to function in cell differentiation (Merenmies, J., and Rauvala, H. (1990) J. Biol. Chem. 265, 16721-16724). The same sequence was found for the mitogenic and neurite outgrowth-promoting protein pleiotrophin (Li, Y.-S., Milner, P. G., Chauhan, A. K., Watson, M. A., Hoffman, R. M., Kodner, C. M., Milbrandt, J., and Deuel, T. F. (1990) Science 250, 1690-1694). In this study, we have constructed a recombinant baculovirus using the cDNA that encodes the putative preprotein of HB-GAM. The putative secretion signal of HB-GAM is cleaved off in the baculovirus expression system, and the recombinant protein is rapidly secreted to the culture medium. Recombinant HB-GAM purified from the culture medium retains the biochemical characteristics and the neurite outgrowth-promoting activity found for the tissue-derived protein. Studies on the neurite outgrowth-promoting activity suggest that HB-GAM functions as an extracellular matrix-associated protein that enhances axonal growth in perinatal cerebral neurons of the rat. Since the same predicted amino acid sequence has been ascribed to a mitogenic protein, mitogenic activities of the recombinant HB-GAM and of tissue-derived HB-GAM fractions were also studied. Recombinant HB-GAM did not display any significant mitogenic activity, suggesting that tissue-derived HB-GAM preparations may contain other heparin-binding mitogenic factors. We identified in brain-derived HB-GAM fractions a 17-kDa protein (p17) that is detached from heparin by a slightly higher salt concentration as compared to HB-GAM. We suggest that p17 is structurally distinct from HB-GAM and responsible for the mitogenic actions of tissue-derived HB-GAM fractions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597470

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras.

Authors:  N Yoshioka; H Inoue; K Nakanishi; K Oka; M Yutsudo; A Yamashita; A Hakura; H Nojima
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Interaction of fimbriae of Haemophilus influenzae type B with heparin-binding extracellular matrix proteins.

Authors:  R Virkola; M Brummer; H Rauvala; L van Alphen; T K Korhonen
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  The actin-driven movement and formation of acetylcholine receptor clusters.

Authors:  Z Dai; X Luo; H Xie; H B Peng
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

4.  Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.

Authors:  Weiwen Wang; Michelle E LeBlanc; Xiuping Chen; Ping Chen; Yanli Ji; Megan Brewer; Hong Tian; Samantha R Spring; Keith A Webster; Wei Li
Journal:  Angiogenesis       Date:  2017-04-26       Impact factor: 9.596

5.  Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury.

Authors:  H J Yeh; Y Y He; J Xu; C Y Hsu; T F Deuel
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

Review 6.  Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules.

Authors:  M Salmivirta; M Jalkanen
Journal:  Experientia       Date:  1995-09-29

Review 7.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors:  Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

8.  Receptor type protein tyrosine phosphatase zeta-pleiotrophin signaling controls endocytic trafficking of DNER that regulates neuritogenesis.

Authors:  Nobuna Fukazawa; Seisuke Yokoyama; Mototsugu Eiraku; Mineko Kengaku; Nobuaki Maeda
Journal:  Mol Cell Biol       Date:  2008-05-12       Impact factor: 4.272

9.  The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.

Authors:  Peter Landgraf; Petra Wahle; Hans-Christian Pape; Eckart D Gundelfinger; Michael R Kreutz
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

10.  Mapping the midkine family of developmentally regulated signaling molecules.

Authors:  C L Peichel; S W Scherer; L C Tsui; D R Beier; T F Vogt
Journal:  Mamm Genome       Date:  1993-11       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.